Alterations in Fas (CD 95/Apo-1) and Fas ligand (CD178) expression in acute promyelocytic leukemia during treatment with ATRA.
Salih, Helmut R
Alterations in Fas (CD 95/Apo-1) and Fas ligand (CD178) expression in acute promyelocytic leukemia during treatment with ATRA. [electronic resource] - Leukemia & lymphoma Jan 2004 - 55-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1042-8194
10.1080/1042819031000139684 doi
Fas Ligand Protein
Humans
Leukemia, Promyelocytic, Acute--drug therapy
Membrane Glycoproteins--metabolism
Tretinoin--therapeutic use
fas Receptor--metabolism
Alterations in Fas (CD 95/Apo-1) and Fas ligand (CD178) expression in acute promyelocytic leukemia during treatment with ATRA. [electronic resource] - Leukemia & lymphoma Jan 2004 - 55-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1042-8194
10.1080/1042819031000139684 doi
Fas Ligand Protein
Humans
Leukemia, Promyelocytic, Acute--drug therapy
Membrane Glycoproteins--metabolism
Tretinoin--therapeutic use
fas Receptor--metabolism